Potential of PET to predict the response to trastuzumab treatment in an ErbB2-positive human xenograft tumor model. by Kramer-Marek, G, Gijsen, M, Kiesewetter, DO, Bennett, R, Roxanis, I, Zielinski, R, Kong, A, Capala, J

Distributable, metabolic PET reporting of tuberculosis by Khan, RMN, Ahn, Y, Marriner, GA, Via, LE, D’Hooge, F, Seo Lee, S, Yang, N, Basuli, F, White, AG, Tomko, JA, Frye, LJ, Scanga, CA, Weiner, DM, Sutphen, ML, Schimel, DM, Dayao, E, Piazza, MK, Gomez, F, Dieckmann, W, Herscovitch, P, Mason, NS, Swenson, R, Kiesewetter, DO, Backus, KM, Geng, Y, Raj, R, Anthony, DC, Davis, BG